This article details a comprehensive study on the progression of borderline ovarian tumors to metastatic low-grade serous cancer. Researchers utilized spatial proteo-transcriptomic profiling, integrating both proteomics and transcriptomics at a cellular level, to map the molecular changes during this transition. The study identifies micropapillary borderline tumors as an intermediate stage and pinpoints specific drivers of cancer transformation. Ultimately, the authors present mechanistic evidence supporting new combination treatments for this chemo-resistant disease, validating potential therapeutic targets through in vitro and in vivo experiments.

References:

• Schweizer L, Kenny H A, Krishnan R, et al. Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression[J]. Cancer Cell, 2025.